Biocept (BIOC) Misses Q2 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/11/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
- AppLovin gains market share among e-commerce advertisers
Biocept Reports Second Quarter 2021 Financial Results
August 16, 2021 4:05 PM EDTSecond quarter revenues of $12.0 million driven by RT-PCR COVID-19 testing Continued sequential-quarter CNSide volume growth with customer base expanding to more than 30 leading U.S. academic institutions, including multiple repeat users Issued coverage with high-value payment by Medicare for the Target Selector breast cancer assay to detect the HER2 biomarker Received nearly 500,000 samples for COVID-19 RT-PCR testing since June 2020
Conference call begins at 4:30 p.m. Eastern time today
SAN DIEGO--(BUSINESS... More
